European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
Checklist for the submission of product information annexes and Annex A (if applicable) for minor procedures without linguistic review - human
Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Status: Authorised
Template - Application for transfer of marketing authorisation from transferor to transferee - cover letter (human)
Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Date of authorisation: 25/04/2025, Status: Authorised
Article 57 product data
Agenda of the CAT meeting 16-18 July 2025
Clinical pharmacology and pharmacokinetics: questions and answers
European Platform for Regulatory Science Research meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 May 2025, 14:00 (CEST) to 20 May 2025, 16:30 (CEST)